Abstract 10937: Incidence of Cardiac Complications During Index Hospitalisation with COVID-19 in Australia: AUS-COVID Study

• Published in: Circulation (New York, N.Y.) Vol. 144; no. Suppl_1; p. A10937
• Main Authors: Bhatia, Kunwardeep S, Sritharan, Hari P, Justin, Chia, Ciofani, Jonathan, Allahwala, Usaid, Chui, Karina, Nour, Daniel, Vasanthakumar, Sheran, Kandadai, Dhanvee, Bhagwandeen, Rohan, Brieger, David, Choong, Christopher, Delaney, Anthony, Dwivedi, Girish, Harris, Benjamin, Hillis, Graham, Hudson, Bernard, Javorsky, George, Jepson, Nigel, Kanagaratnam, Logan, Kotsiou, George, Lee, Astin, Lo, Sidney, Macisaac, Andrew I, McQuillan, Brendan, Ranasinghe, Isuru, Walton, Tony, Weaver, James, Wilson, William, Yong, Andy, Zhu, John, van Gaal, William, Kritharides, Leonard, Chow, Clara K, Bhindi, Ravinay
• Format: Journal Article
• Language: English
• Published: Lippincott Williams & Wilkins 16-11-2021
• ISSN: 0009-7322; 1524-4539
• DOI: 10.1161/circ.144.suppl_1.10937

IntroductionCardiac complications of COVID-19 include acute cardiac injury, myopericarditis, cardiomyopathy and arrhythmias. This study aimed to describe the incidence of cardiac complications in patients admitted to hospital with COVID-19 in Australia. MethodsAUS-COVID is a multicentre observational cohort study across 21 Australian hospitals including all index hospitalisations with laboratory-proven COVID-19 in patients aged 18 years or older. All consecutive patients entered in the AUS-COVID Registry by 28th January 2021 were included in the present study. ResultsSix hundred and forty-four hospitalised patients (62.5 ± 20.1 years old, 51.1% male) with COVID-19 were enrolled in the study. Overall in-hospital mortality was 14.3%. Twenty (3.6%) patients developed new atrial fibrillation or flutter during admission and 9 (1.6%) patients were diagnosed with new heart failure or cardiomyopathy. Three (0.5%) patients developed high grade atrioventricular (AV) block. Two (0.3%) patients were clinically diagnosed with pericarditis or myopericarditis. Among the 295 (45.8%) patients with at least one troponin measurement, 99 (33.6%) had a peak troponin above the upper limit of normal (ULN). In-hospital mortality was higher in patients with raised troponin (32.3% vs 6.1%, p<.001). New onset atrial fibrillation or flutter (6.4% vs 1.0%, p=.001) and troponin elevation above the ULN (50.3% vs 16.4%, p<.001) were more common in patients 65 years and older. There was no significant difference in the rate of cardiac complications between males and females. ConclusionsAmong patients with COVID-19 requiring hospitalisation in Australia, troponin elevation was common but clinical cardiac sequelae were uncommon. The incidence of atrial arrhythmias and troponin elevation was greatest in patients 65 years and older. Trial registrationAUS-COVID. ACTRN12620000486921. http://www.anzctr.org.au/